CytRx to Present at the Rodman & Renshaw Annual Healthcare Conference

• Press Release
• Source: CytRx Corporation
• On 8:30 am EDT, Friday September 4, 2009

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR - News) today announced that CytRx President and CEO Steven A. Kriegsman will present a corporate overview at the Rodman & Renshaw 11^th Annual Healthcare Conference on Wednesday, September 9, at 2:25 p.m. Eastern time (11:25 a.m. Pacific time). The conference is being held at the New York Palace Hotel in New York City. A live webcast of the presentation will be available at www.cytrx.com and a replay of the webcast will be archived on the Company’s Web site for 90 days.

Related Quotes

Symbol	Price	Change
CYTR	1.05	-0.03

{"s" : "cytr","k" : "c10,l10,p20,t10","o" : "","j" : ""}

About CytRx Corporation

CytRx Corporation is a biopharmaceutical research and development company engaged in the development of high-value human therapeutics. The CytRx drug development pipeline includes programs in clinical development for cancer indications, including tamibarotene in a registration study for the treatment of acute promyelocytic leukemia (APL). In addition, CytRx is developing two drug candidates based on its industry-leading molecular chaperone technology, which aims to repair or degrade misfolded proteins associated with disease. CytRx also maintains a 39% equity interest in publicly traded RXi Pharmaceuticals, Inc. (NASDAQ:RXII - News). For more information on the Company, visit www.cytrx.com.

Legend Securities, Inc.
Thomas Wagner
800-385-5790 x152
718-233-2600 x152
twagner@legendsecuritiesinc.com